Bull
$59.37
Scenario price
$70.810
+2.252 (+3.18%)At close
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
Centene Corp (CNC) is a good buy right now, trading at $69.16 with a forward P/E ratio of 11.22, indicating potential for growth. The stock has shown strong momentum, with a 5-day change of +5.81% and a year-to-date change of +65.53%. However, there is a risk of volatility with the recent negative earnings surprises, including a net loss of $13.50 per share in Q3 2025, which may affect investor sentiment.
BofA
$80
2026-09-11
BofA
2026-09-11
Price Target
$80
Argus
$80
2026-08-11
Argus
2026-08-11
Price Target
$80
JPMorgan
$67
2026-08-04
JPMorgan
2026-08-04
Price Target
$67
Bernstein
$79
2026-08-03
Bernstein
2026-08-03
Price Target
$79
Morgan Stanley
$66
2026-07-29
Morgan Stanley
2026-07-29
Price Target
$66
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Centene to Release Q3 2026 Financial Results and Host Conference Call

Ambetter Health Introduces New Heart Failure Coverage and Expands Chronic Care Solutions

Ambetter Health Introduces New Heart Failure Coverage and Expands Chronic Care Solutions

PA Health & Wellness Recognized Among Top Medicaid Plans for Second Year

Centene Launches National Performance-Based Gold Card Program
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Centene Corp (CNC) is a good buy right now, trading at $69.16 with a forward P/E ratio of 11.22, indicating potential for growth. The stock has shown strong momentum, with a 5-day change of +5.81% and a year-to-date change of +65.53%. However, there is a risk of volatility with the recent negative earnings surprises, including a net loss of $13.50 per share in Q3 2025, which may affect investor sentiment.
17 analysts cover CNC: 12 rate it Buy, 5 Hold and 0 Sell. The average price target is 43.07.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.